| 000 | 01768 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516154405.0 | ||
| 264 | 0 | _c20140106 | |
| 008 | 201401s 0 0 eng d | ||
| 022 | _a1559-2308 | ||
| 024 | 7 |
_a10.4161/epi.24710 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRajendran, Praveen | |
| 245 | 0 | 0 |
_aHDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates. _h[electronic resource] |
| 260 |
_bEpigenetics _cJun 2013 |
||
| 300 |
_a612-23 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAcetylation |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aAutophagy |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 | _aCell Cycle Checkpoints |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aColon _xcytology |
| 650 | 0 | 4 |
_aColonic Neoplasms _xgenetics |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 | _aEndodeoxyribonucleases |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aHistone Deacetylase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHistone Deacetylases _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIsothiocyanates _xadministration & dosage |
| 650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
| 650 | 0 | 4 | _aSulfoxides |
| 700 | 1 | _aKidane, Ariam I | |
| 700 | 1 | _aYu, Tian-Wei | |
| 700 | 1 | _aDashwood, Wan-Mohaiza | |
| 700 | 1 | _aBisson, William H | |
| 700 | 1 | _aLöhr, Christiane V | |
| 700 | 1 | _aHo, Emily | |
| 700 | 1 | _aWilliams, David E | |
| 700 | 1 | _aDashwood, Roderick H | |
| 773 | 0 |
_tEpigenetics _gvol. 8 _gno. 6 _gp. 612-23 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4161/epi.24710 _zAvailable from publisher's website |
| 999 |
_c22839816 _d22839816 |
||